Limin Liu

机构：Beihang University · ORCID：0000-0001-9006-5155

发表论文 86 篇 · 总被引 1091 次 · h-index 16

代表论文

• Quantitative anti-HBc combined with quantitative HBsAg can predict HBsAg clearance in sequential combination therapy with PEG-IFN-α in NA-suppressed chronic hepatitis B patients (2022 · Frontiers in Immunology · 被引 29)
• Early Omicron infection is associated with increased reinfection risk in older adults in long-term care and retirement facilities (2023 · EClinicalMedicine · 被引 21)
• Matched related transplantation versus immunosuppressive therapy plus eltrombopag for first-line treatment of severe aplastic anemia: a multicenter, prospective study (2022 · Journal of Hematology & Oncology · 被引 18)
• Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia (2024 · Blood Cancer Journal · 被引 10)
• Treatments of Ph-like acute lymphoblastic leukemia: a real-world retrospective analysis from a single large center in China (2022 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 10)
• Ferroptosis: A therapeutic opportunity of inflammatory bowel disease (2024 · Chinese Medical Journal · 被引 9)